Changing Treatment Landscape in Soft Tissue Sarcoma
3 意见
• 07/18/23
0
0
嵌入
Saketh Guntupalli, MD, and Victor Villalobos, MD, PhD, discuss the emergence of olaratumab as an option for patients with advanced, unresectable soft tissue sarcoma, and how it has impacted the treatment landscape.
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论